Inositol polyphosphates contribute to cellular circadian rhythms: Implications for understanding lithium's molecular mechanism

Cellular Signalling

Volumn 44, Issue , 2018, Pages 82-91

  Wei, Heather ^a,b   Landgraf, Dominic ^b   Wang, George ^b   McCarthy, Michael J ^a,b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Circadian rhythms; Glycogen synthase kinase 3; Inositol; Inositol hexaphosphate; Inositol pyrophosphate; Lithium

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; INOSITOL PENTAKISPHOSPHATE 2 KINASE; INOSITOL POLYPHOSPHATE; INOSITOL POLYPHOSPHATE MULTIKINASE; LITHIUM; PHOSPHOTRANSFERASE; PHYTIC ACID; PROTEIN KINASE B; SERINE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; GLYCOGEN SYNTHASE KINASE 3; INOSITOL PENTAKISPHOSPHATE KINASE;

ANIMAL CELL; ARTICLE; BIOLUMINESCENCE; CIRCADIAN RHYTHM; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE KNOCKDOWN; INTRACELLULAR SIGNALING; MOUSE; NERVE CELL; NIH 3T3 CELL LINE; NONHUMAN; PRIORITY JOURNAL; SYNTHESIS; ANIMAL; DRUG EFFECT; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; CIRCADIAN RHYTHM; GENE KNOCKDOWN TECHNIQUES; GLYCOGEN SYNTHASE KINASE 3; LITHIUM; MICE; NIH 3T3 CELLS; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PHYTIC ACID; RNA, SMALL INTERFERING;

EID: 85041467373     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2018.01.001     Document Type: Article

References (39)

1. Liu, A.C., Welsh, D.K., Ko, C.H., Tran, H.G., Zhang, E.E., Priest, A.A., Buhr, E.D., Singer, O., Meeker, K., Verma, I.M. et al., Intercellular coupling confers robustness against mutations in the SCN circadian clock network. Cell 129:3 (2007), 605–616.
2. McCarthy, M.J., Welsh, D.K., Cellular circadian clocks in mood disorders. J. Biol. Rhythm. 27:5 (2012), 339–352.
3. Cronin, P., McCarthy, M.J., Lim, A.S., Salmon, D.P., Galasko, D., Masliah, E., De Jager, P.L., Bennett, D.A., Desplats, P., Circadian alterations during early stages of Alzheimer's disease are associated with aberrant cycles of DNA methylation in BMAL1. Alzheimers Dement. 13 (2017), 689–700.
4. Lamia, K.A., Storch, K.F., Weitz, C.J., Physiological significance of a peripheral tissue circadian clock. Proc. Natl. Acad. Sci. U. S. A. 105:39 (2008), 15172–15177.
5. Fu, L., Lee, C.C., The circadian clock: pacemaker and tumour suppressor. Nat. Rev. Cancer 3:5 (2003), 350–361.
6. Iitaka, C., Miyazaki, K., Akaike, T., Ishida, N., A role for glycogen synthase kinase-3beta in the mammalian circadian clock. J. Biol. Chem. 280:33 (2005), 29397–29402.
7. Yin, L., Wang, J., Klein, P.S., Lazar, M.A., Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock. Science 311:5763 (2006), 1002–1005.
8. Harada, Y., Sakai, M., Kurabayashi, N., Hirota, T., Fukada, Y., Ser-557-phosphorylated mCRY2 is degraded upon synergistic phosphorylation by glycogen synthase kinase-3 beta. J. Biol. Chem. 280:36 (2005), 31714–31721.
9. Hirota, T., Lewis, W.G., Liu, A.C., Lee, J.W., Schultz, P.G., Kay, S.A., A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3beta. Proc. Natl. Acad. Sci. U. S. A. 105:52 (2008), 20746–20751.
10. Li, J., WQ, Lu, Beesley, S., Loudon, A.S., Meng, Q.J., Lithium impacts on the amplitude and period of the molecular circadian clockwork. PLoS One, 7(3), 2012, e33292.
11. Berridge, M.J., Downes, C.P., Hanley, M.R., Neural and developmental actions of lithium: a unifying hypothesis. Cell 59:3 (1989), 411–419.
12. Chakraborty, A., Kim, S., Snyder, S.H., Inositol pyrophosphates as mammalian cell signals. Sci. Signal., 4(188), 2011, re1.
13. Shears, S.B., Inositol pentakis- and hexakisphosphate metabolism adds versatility to the actions of inositol polyphosphates. Novel effects on ion channels and protein traffic. Subcell. Biochem. 26 (1996), 187–226.
14. Yang, S.N., Shi, Y., Yang, G., Li, Y., Yu, L., Shin, O.H., Bacaj, T., Sudhof, T.C., Yu, J., Berggren, P.O., Inositol hexakisphosphate suppresses excitatory neurotransmission via synaptotagmin-1 C2B domain in the hippocampal neuron. Proc. Natl. Acad. Sci. U. S. A. 109:30 (2012), 12183–12188.
15. 2+ channel activity by stimulation of adenylyl cyclase. FASEB J. 15:10 (2001), 1753–1763.
16. Valastro, B., Girard, M., Gagne, J., Martin, F., Parent, A.T., Baudry, M., Massicotte, G., Inositol hexakisphosphate-mediated regulation of glutamate receptors in rat brain sections. Hippocampus 11:6 (2001), 673–682.
17. 2+ channel activity by inositol hexakisphosphate. Science 278:5337 (1997), 471–474.
18. McCarthy, M.J., LeRoux, M., Wei, H., Beesley, S., Kelsoe, J.R., Welsh, D.K., Calcium channel genes associated with bipolar disorder modulate lithium's amplification of circadian rhythms. Neuropharmacology, 101, 2016, 439-48.
19. Wilson, M.S., Bulley, S.J., Pisani, F., Irvine, R.F., Saiardi, A., A novel method for the purification of inositol phosphates from biological samples reveals that no phytate is present in human plasma or urine. Open Biol., 5(3), 2015, 150014.
20. Windhorst, S., Lin, H., Blechner, C., Fanick, W., Brandt, L., Brehm, M.A., Mayr, G.W., Tumour cells can employ extracellular Ins(1,2,3,4,5,6)P(6) and multiple inositol-polyphosphate phosphatase 1 (MINPP1) dephosphorylation to improve their proliferation. Biochem. J. 450:1 (2013), 115–125.
21. Riley, A.M., Windhorst, S., Lin, H.Y., Potter, B.V., Cellular internalisation of an inositol phosphate visualised by using fluorescent InsP5. Chembiochem 15:1 (2014), 57–67.
22. Mukai, T., Kishi, T., Matsuda, Y., Iwata, N., A meta-analysis of inositol for depression and anxiety disorders. Hum. Psychopharmacol. 29:1 (2014), 55–63.
23. Chakraborty, A., Koldobskiy, M.A., Bello, N.T., Maxwell, M., Potter, J.J., Juluri, K.R., Maag, D., Kim, S., Huang, A.S., Dailey, M.J. et al., Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain. Cell 143:6 (2010), 897–910.
24. Chakraborty, A., Latapy, C., Xu, J., Snyder, S.H., Beaulieu, J.M., Inositol hexakisphosphate kinase-1 regulates behavioral responses via GSK3 signaling pathways. Mol. Psychiatry 19:3 (2014), 284–293.
25. McCarthy, M.J., Wei, H., Marnoy, Z., Darvish, R.M., McPhie, D.L., Cohen, B.M., Welsh, D.K., Genetic and clinical factors predict lithium's effects on PER2 gene expression rhythms in cells from bipolar disorder patients. Transl. Psychiatry, 3, 2013, e318.
26. McCarthy, M.J., Wei, H., Landgraf, D., Le Roux, M.J., Welsh, D.K., Disinhibition of the extracellular-signal-regulated kinase restores the amplification of circadian rhythms by lithium in cells from bipolar disorder patients. Eur. Neuropsychopharmacol. 26:8 (2016), 1310–1319.
27. Sutherland, C., Leighton, I.A., Cohen, P., Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem. J. 296:Pt 1 (1993), 15–19.
28. Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M., Hemmings, B.A., Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:6559 (1995), 785–789.
29. Ryves, W.J., Harwood, A.J., Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem. Biophys. Res. Commun. 280:3 (2001), 720–725.
30. Gao, Y., Wang, H.Y., Inositol pentakisphosphate mediates Wnt/beta-catenin signaling. J. Biol. Chem. 282:36 (2007), 26490–26502.
31. Sneyd, J., Wetton, B.T., Charles, A.C., Sanderson, M.J., Intercellular calcium waves mediated by diffusion of inositol trisphosphate: a two-dimensional model. Am. J. Phys. 268:6 Pt 1 (1995), C1537–1545.
32. Maag, D., Maxwell, M.J., Hardesty, D.A., Boucher, K.L., Choudhari, N., Hanno, A.G., Ma, J.F., Snowman, A.S., Pietropaoli, J.W., Xu, R. et al., Inositol polyphosphate multikinase is a physiologic PI3-kinase that activates Akt/PKB. Proc. Natl. Acad. Sci. U. S. A. 108:4 (2011), 1391–1396.
33. Besing, R.C., Paul, J.R., Hablitz, L.M., Rogers, C.O., Johnson, R.L., Young, M.E., Gamble, K.L., Circadian rhythmicity of active GSK3 isoforms modulates molecular clock gene rhythms in the suprachiasmatic nucleus. J. Biol. Rhythm. 30:2 (2015), 155–160.
34. Paul, J.R., Johnson, R.L., Jope, R.S., Gamble, K.L., Disruption of circadian rhythmicity and suprachiasmatic action potential frequency in a mouse model with constitutive activation of glycogen synthase kinase 3. Neuroscience 226 (2012), 1–9.
35. Ahn, J., Jang, J., Choi, J., Lee, J., SH, Oh., Yoon, K., Kim, S., GSK3beta, but not GSK3alpha, inhibits the neuronal differentiation of neural progenitor cells as a downstream target of mammalian target of rapamycin complex1. Stem Cells Dev. 23:10 (2014), 1121–1133.
36. Kaidanovich-Beilin, O., Lipina, T.V., Takao, K., van Eede, M., Hattori, S., Laliberte, C., Khan, M., Okamoto, K., Chambers, J.W., Fletcher, P.J. et al., Abnormalities in brain structure and behavior in GSK-3alpha mutant mice. Mol. Brain, 2, 2009, 35.
37. Grases, F., Simonet, B.M., Vucenik, I., Perello, J., Prieto, R.M., Shamsuddin, A.M., Effects of exogenous inositol hexakisphosphate (InsP(6)) on the levels of InsP(6) and of inositol trisphosphate (InsP(3)) in malignant cells, tissues and biological fluids. Life Sci. 71:13 (2002), 1535–1546.
38. Grases, F., Simonet, B.M., Vucenik, I., Prieto, R.M., Costa-Bauza, A., March, J.G., Shamsuddin, A.M., Absorption and excretion of orally administered inositol hexaphosphate (IP(6) or phytate) in humans. Biofactors 15:1 (2001), 53–61.
39. Letcher, A.J., Schell, M.J., Irvine, R.F., Do mammals make all their own inositol hexakisphosphate?. Biochem. J. 416:2 (2008), 263–270.